Genpact Limited (G) Director James C. Madden Sells 4,270 Shares of Stock

Genpact Limited (NYSE:G) Director James C. Madden sold 4,270 shares of the stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $30.92, for a total value of $132,028.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Genpact Limited (NYSE G) traded up $0.14 on Friday, hitting $31.59. The stock had a trading volume of 563,648 shares, compared to its average volume of 841,735. The stock has a market cap of $6,064.35, a PE ratio of 23.57, a PEG ratio of 2.03 and a beta of 0.57. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.77. Genpact Limited has a 52 week low of $23.34 and a 52 week high of $34.79.

Genpact (NYSE:G) last released its earnings results on Monday, February 12th. The business services provider reported $0.43 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.02. The company had revenue of $734.41 million during the quarter, compared to analysts’ expectations of $723.55 million. Genpact had a return on equity of 23.53% and a net margin of 9.61%. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 EPS. sell-side analysts predict that Genpact Limited will post 1.55 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 21st. Stockholders of record on Friday, March 9th will be paid a $0.075 dividend. This represents a $0.30 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date is Thursday, March 8th. This is a boost from Genpact’s previous quarterly dividend of $0.06. Genpact’s dividend payout ratio (DPR) is presently 17.91%.

Several equities research analysts have weighed in on the company. JPMorgan Chase & Co. dropped their price objective on Genpact from $38.00 to $37.00 and set a “neutral” rating for the company in a report on Wednesday. BMO Capital Markets increased their price objective on Genpact to $35.00 and gave the stock a “market perform” rating in a report on Tuesday. Robert W. Baird reiterated a “buy” rating and issued a $38.00 price objective on shares of Genpact in a report on Friday, November 10th. Zacks Investment Research cut Genpact from a “hold” rating to a “sell” rating in a report on Thursday. Finally, Citigroup dropped their price objective on Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company’s stock. Genpact presently has an average rating of “Buy” and a consensus price target of $34.65.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company lifted its stake in shares of Genpact by 7.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after purchasing an additional 455 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of Genpact by 3.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 30,196 shares of the business services provider’s stock valued at $840,000 after purchasing an additional 907 shares during the period. Sit Investment Associates Inc. lifted its stake in shares of Genpact by 4.5% in the 4th quarter. Sit Investment Associates Inc. now owns 37,100 shares of the business services provider’s stock valued at $1,178,000 after purchasing an additional 1,590 shares during the period. FDx Advisors Inc. lifted its stake in shares of Genpact by 2.9% in the 3rd quarter. FDx Advisors Inc. now owns 61,488 shares of the business services provider’s stock valued at $1,768,000 after purchasing an additional 1,713 shares during the period. Finally, Commerzbank Aktiengesellschaft FI lifted its stake in shares of Genpact by 12.4% in the 3rd quarter. Commerzbank Aktiengesellschaft FI now owns 16,466 shares of the business services provider’s stock valued at $473,000 after purchasing an additional 1,816 shares during the period. Institutional investors own 92.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://weekherald.com/2018/02/17/genpact-limited-g-director-james-c-madden-sells-4270-shares-of-stock.html.

About Genpact

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Insider Buying and Selling by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply